GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avenir Wellness Solutions Inc (OTCPK:AVRW) » Definitions » EV-to-EBITDA

Avenir Wellness Solutions (Avenir Wellness Solutions) EV-to-EBITDA : -1.05 (As of May. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Avenir Wellness Solutions EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Avenir Wellness Solutions's enterprise value is $10.73 Mil. Avenir Wellness Solutions's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-10.19 Mil. Therefore, Avenir Wellness Solutions's EV-to-EBITDA for today is -1.05.

The historical rank and industry rank for Avenir Wellness Solutions's EV-to-EBITDA or its related term are showing as below:

AVRW' s EV-to-EBITDA Range Over the Past 10 Years
Min: -71.54   Med: -5.14   Max: -0.92
Current: -1.05

During the past 8 years, the highest EV-to-EBITDA of Avenir Wellness Solutions was -0.92. The lowest was -71.54. And the median was -5.14.

AVRW's EV-to-EBITDA is ranked worse than
100% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.53 vs AVRW: -1.05

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-04), Avenir Wellness Solutions's stock price is $0.039. Avenir Wellness Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.143. Therefore, Avenir Wellness Solutions's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Avenir Wellness Solutions EV-to-EBITDA Historical Data

The historical data trend for Avenir Wellness Solutions's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avenir Wellness Solutions EV-to-EBITDA Chart

Avenir Wellness Solutions Annual Data
Trend Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial -6.34 -6.64 -3.38 -6.95 -1.11

Avenir Wellness Solutions Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.24 -1.11 -1.19 -1.44 -1.61

Competitive Comparison of Avenir Wellness Solutions's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Avenir Wellness Solutions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avenir Wellness Solutions's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avenir Wellness Solutions's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Avenir Wellness Solutions's EV-to-EBITDA falls into.



Avenir Wellness Solutions EV-to-EBITDA Calculation

Avenir Wellness Solutions's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=10.731/-10.186
=-1.05

Avenir Wellness Solutions's current Enterprise Value is $10.73 Mil.
Avenir Wellness Solutions's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avenir Wellness Solutions  (OTCPK:AVRW) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Avenir Wellness Solutions's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.039/-0.143
=At Loss

Avenir Wellness Solutions's share price for today is $0.039.
Avenir Wellness Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.143.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Avenir Wellness Solutions EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Avenir Wellness Solutions's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Avenir Wellness Solutions (Avenir Wellness Solutions) Business Description

Traded in Other Exchanges
N/A
Address
5805 Sepulveda Boulevard, Suite 801, Sherman Oaks, CA, USA, 91411
Avenir Wellness Solutions Inc is a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on approximately 15 current patents, offers several immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The company sells its product under the brand names Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips.
Executives
Robert J Costantino director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joel M Bennett officer: CFO,CAO, Treasurer & Secretary 22619 PACIFIC COAST HIGHWAY, MALIBU CA 90265
Gerald Bagg director C/O CURE PHARMACEUTICAL HOLDING CORP., 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Nancy Duitch officer: Chief Strat Officer-Wellness 15950 ROYAL OAK RD, ENCINO CA 91436
Robert Steven Davidson director, officer: CEO & Director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Jonathan Berlent officer: Chief Business Officer 1620 BEACON PLACE, OXNARD CA 93033
John K Bell director 38 FALLBROOK LANE RR 33, CAMBRIDGE A6 N3H 4R8
Anna Goldin director 1620 BEACON STREET, OXNARD CA 93033
Lauren Chung director 1620 BEACON STREET, OXNARD CA 93033
Michael Redard officer: Chief Financial Officer 1620 BEACON PLACE, OXNARD CA 93033
Joshua Held director 1620 BEACON PLACE, OXNARD CA 93033
Climate Change Investigation, Innovation & Investment Company, Llc 10 percent owner 12 SAN RAFAEL AVE, BELVEDERE CA 94920
Ruben Jr King-shaw director 1620 BEACON PLACE, OXNARD CA 93033
Gene Z Salkind director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Alex Katz officer: CFO 1233 FAIRY HILL ROAD, RYDAL PA 19046

Avenir Wellness Solutions (Avenir Wellness Solutions) Headlines

From GuruFocus

CURE Pharmaceutical Letter to Shareholders

By ACCESSWIRE ACCESSWIRE 12-15-2022

Avenir Wellness Solutions Update to Stockholders

By ACCESSWIRE ACCESSWIRE 05-17-2023